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Background
Recent advances in empirical, method-
ological, and theoretical aspects of vector
biology are an impetus for reexamining
critical research needs aimed at improv-
ing human health. The discipline of vec-
tor biology is characterized by its empha-
sis on disease prevention, and successes
are well documented. Vector interventions
were essential for reduction of malaria
and yellow fever in the 1950s and 1960s,
dengue in Singapore and Cuba [1], and
onchocerciasis in West Africa [2]. Unfor-
tunately, victories are too often the excep-
tion, or when they do occur they are diffi-
cult to sustain. Malaria remains among the
biggest infectious disease killers; lymphatic
filariasis has proven difficult to eliminate;
Chagas disease, African trypanosomiasis,
onchocerciasis, and leishmaniasis are un-
derserved; dengue continues to expand
its geographic range; and West Nile and
chikungunya viruses invaded new conti-
nents with little resistance [3,4]. Although
vector control remains an essential com-
ponent in the battle against vector-borne
disease (VBD), persistence of vector-borne
pathogens and resilience of their arthro-
pod vectors continue to motivate the
search for novel solutions.
In the past two decades vector biolo-
gists have responded to this challenge by
reassessing the status of research in their
field [5–8]. Contributions range from an
Institute of Medicine report that, 17 years
ago, identified VBDs as among the most
important emerging microbial threats to
the United States [9] to the current call for
fundamental shifts in areas of emphasis,
execution, and application of VBD re-
search [10]. Reviews revealed progress in
some areas (e.g., genomics, genetics, and
quantitative analyses), while accomplish-
ments in other areas lagged behind expec-
tations (e.g., field evaluation of transgenic
vectors and development of insecticides
with novel modes of action). Common to
all of these reports is the premise that the
overall goal should be to reduce or prevent
pathogen transmission and disease. Ad-
justments in sequential reports dealt with
the perceived best path to reaching that
objective. Across these reviews, recom-
mendations can be distilled to five major
needs: (1) novel intervention tools (e.g.,
new public health insecticides, biological
control agents, and genetics-based instru-
ments [11,12]); (2) improved disease pre-
vention strategies (e.g., integrating differ-
ent vector control strategies and combin-
ing vector control with other prevention
tools, such as drugs and vaccines, to attack
multiple VBDs [1,13]); (3) enhanced sur-
veillance methods and data analysis; (4)
broader integration of scientific subdisci-
plines (e.g., vector biology, clinical re-
search, natural and social environmental
biology); and (5) expanded training oppor-
tunities [12,14].
Identifying Central Issues in
VBD Control
Despite these well-intended recommen-
dations, VBD prevention continues to be
challenged by incomplete coordination
among individuals with complementary
expertise, inability to implement long-term
solutions, and reluctance to embrace the
complexity of vector biology and pathogen
transmission systems in intervention strat-
egies. In this context, an international
meeting of vector biologists (participants
are listed in the acknowledgments section)
was convened at the University of Cali-
fornia, Davis, in January 2008 to develop
a revised agenda based on the principal
theme of improving integration in VBD
management. The meeting format em-
phasized: (1) redefining common challeng-
es and opportunities across a range of
VBDs; (2) initiating and sustaining strate-
gically planned interactions among inves-
tigators within and among a diversity
of research areas; and (3) developing a
working list of research areas that merit
increased attention.
A Challenge Issued
Consistent with the ‘‘working list’’ con-
cept we present the following challenge to
our readers: the content of this article must
be modified through vigorous and open
discussion of supportive, dissenting, and
divergent opinions to consolidate owner-
ship of a collective agenda that results
in action, reaction, collaboration, and
change. We appreciate the support of the
Public Library of Science to moderate
these first steps through submission of
online comments and discussion by mem-
bers of our community and others who
would like to contribute to this process.
Themes and Strategies
The most significant outcome of the
meeting was the identification of three
overarching themes: integration, sustain-
ability, and heterogeneity. Integration of
tools and strategies is necessary to increase
the potential for improved public health
outcomes across different diseases, trans-
Citation: Luckhart S, Lindsay SW, James AA, Scott TW (2010) Reframing Critical Needs in Vector Biology and
Management of Vector-Borne Disease. PLoS Negl Trop Dis 4(2): e566. doi:10.1371/journal.pntd.0000566
Editor: Ellis McKenzie, Fogarty International NIH, United States of America
Published February 23, 2010
Copyright:  2010 Luckhart et al. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
Funding: This document is a summary of thoughts and ideas presented at a meeting (January 2008,
‘‘Emerging Barriers to the Management of Vector-Borne Diseases’’) funded in part by the United States-Japan
Cooperative Medical Sciences Program Parasitic Diseases Panel and the National Institutes of Allergy and
Infectious Diseases Office of Rare Diseases. The Mosquito Research Laboratory of UC Davis provided funds to
defray the costs of publication.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sluckhart@ucdavis.edu
www.plosntds.org 1 February 2010 | Volume 4 | Issue 2 | e566mission ecologies, and epidemiologic set-
tings. In these contexts, sustainability of
VBD prevention is essential. Although
some short-term victories are necessary,
greater emphasis should be placed on
programs anticipated to have a sustained
positive public health impact. Heterogeneity
is a fundamental component of patterns
and processes in VBD transmission. Con-
sequently, variation in the biology, ecolo-
gy, and genetics of vectors and pathogens
and the impact of these phenomena on
pathogen transmission and disease must
be more fully accounted for in integrated
programs to ensure continued, successful
disease prevention.
By combining the strengths of different
approaches, a specific strategy can act
faster, last longer, and be leveraged against
more than one vector or disease. The
theory and practice of integrated pest
management purport that multidimen-
sional strategies are superior to a single,
narrowly focused approach [15]. This is
consistent with the World Health Organi-
zation (WHO) expanded concept for
integrated vector management (IVM) for
vector control using currently available
technology, but also endorses new and
continued research on pathogen transmis-
sion dynamics and tools and strategies for
disease prevention that will fundamentally
and significantly improve public health.
IVM is defined as ‘‘a rational decision-
making process for the optimal use of
resources for vector control’’ [16] and is
based on the use of sustainable vector
control methods alone or in combination
to reduce contact between humans and
vector arthropods [16]. Sustainability de-
rives from cost-effective decision-making
that enfranchises participants at the com-
munity level and that is integrated at the
national and international levels [17,18].
Where reasonable, IVM approaches
should be integrated with clinical inter-
ventions, epidemiological studies, public
health management of water availability
and quality, and management of land-use
and agricultural pests, which collectively
influence VBD transmission, to achieve
control that is economically, socially, and
ecologically sustainable.
The discussion that follows is intended
to be a cross-sectional view of VBD
research in contrast to more traditional
‘‘siloed’’ approaches that are defined by
individual diseases or vector species.
Details of research areas identified as
requiring additional attention are provid-
ed as Supporting Information (Tables S1,
S2, S3, S4). Selected research examples
are used to illustrate key points of the three
overarching themes.
Integration
Control Methods and Strategies
Integrated control methods that target
multiple vectors and multiple diseases and
focus disease prevention on interrupting
human-vector contact are urgently needed
(Table S2, C). An example is La Casa Segura
or ‘‘the safe home’’ concept [19], an
intervention based on delivery of insecticides
into domestic dwellings, which are assumed
to be the primary site of human–insect
interaction and thus pathogen transmission.
This approach and methods like it have not
been evaluated in large-scale efforts against
a specific disease (e.g., malaria or dengue),
while simultaneously leveraging reductions
in a variety of NTDs (e.g., Chagas disease,
human African trypanosomiasis, and leish-
maniasis) and insect pest species.
Integration of entomological, epidemio-
logical, and ecological (both natural and
social) data in risk models is needed to
optimize location- and situation-specific
control strategies (Table S1, B; Table S3,
C). The Pacific Program to Eliminate
Lymphatic Filariasis is an example of an
intervention that evolved into an integrat-
ed program. Initial efforts were based on
mass drug administration, but now include
vector control. The integrated approach is
showing greater impact than when only
drugs were used and after the program-
matic vision was expanded to include
lymphatic filariasis, malaria, and dengue.
Similarly, the Southern Cone initiative to
eliminate Chagas disease from endemic
South America is a case study in successful
integration [20]. Public health profession-
als and vector biologists integrated surveil-
lance of blood supplies and donor screen-
ing with triatomine vector control and
surveillance, transmission modeling, and
community-based educational programs
for sustainable Chagas disease control at
the community level across an array of
ecological settings [20]. Evolution of
Chagas control towards ecosystem man-
agement [21] is a concept that merits
evaluation for other VBDs.
Ideally, field-collected data are integrat-
ed in real time into decision support
systems – which include mathematical,
simulation, or statistical models (Table S3,
C) – that can inform appropriate control
strategies for specific conditions and geo-
graphical areas [19]. In this way vector
control programs can adapt strategies to
the unique features of local conditions,
and systematically predict the benefits of
integration across interventions (e.g.,
drugs, vaccines, and efforts to manage
coinfections that alter host immunity
[22] Table S1, A; Table S4, B). Surveill-
ance tools and analytical models, within
decision support systems, should help to
identify interventions that might inadver-
tently enhance pathogen transmission [23];
they should also be sufficiently flexible to
accommodate emerging or resurging path-
ogens and vectors (Table S2, B; Table S4,
E). Emerging VBDs can arise through
changes in pathogen virulence, the intro-
duction of new vectors or vertebrate
hosts, or anthropogenic changes [24] and,
therefore, can be difficult to identify. For
example, during the initial stages of its
invasion into North America, West Nile
virus was misidentified as St. Louis enceph-
alitis virus [25].
Newer approaches and technologies
(e.g., novel insecticides and repellents
and genetic strategies) will by necessity
be transitioned into existing programs that
are composed of extant tools (e.g., biocon-
trol agents, surveillance tools and methods,
and modeling) [26]. A key missing tech-
nology for vector control is rapid, high-
throughput detection of insecticide resis-
tance (Table S2, A). Such detection is
needed because the frequency of resistant
alleles in a population as measured by
current technology can increase rapidly
from undetectable to very common, such
that resistance cannot be reversed. There-
fore, management of insecticide resistance
should be a priority to extend the useful
life of currently available and future
insecticides [11].
There is a significant need for integra-
tion across control programs to assess
different strategies and tools in different
public health, epidemiologic, and ecologic
settings (Table S2, C). Although some
aspects of control will require approaches
that are case-specific, cooperation and
communication across a broad spectrum
of control programs allows the identifica-
tion of ‘‘common denominators’’ that have
not been harnessed for maximum benefit.
In an analogous fashion, there is an
opportunity to join the movement toward
integrated interventions that are based on
the geographic overlap of high-prevalence
NTDs. For example, NTD clinical man-
agement can be enhanced by integrating
disease-specific drug administration efforts
and creating a ‘‘rapid impact’’ package of
free or low-cost generic drugs [27]. In
particular, filariasis, onchocerciasis, schis-
tosomiasis, soil-transmitted helminth in-
fections, and trachoma could be managed
in sub-Saharan Africa by concurrent pro-
vision of four drugs. This measure would
save time and money and provide maxi-
mum health benefit to populations that are
difficult to access [28]. As practitioners,
vector biologists should study these ap-
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how they could improve existing VBD
prevention programs.
Research
A greater emphasis on applied research
and the application of basic research in
disease endemic settings would be an
important step in closing the gap between
field and laboratory research (Table S4,
D). Although efforts have been made to
integrate work from laboratory to field and
from field to laboratory, more progress is
possible and needed (Table S1, A). It is
important to validate laboratory-based
results in the field (Table S4, E), where
vectors naturally transmit pathogens. On
the other hand, laboratory studies often
can be more elegantly controlled than
field studies and when informed by field
data can be used to develop useful model
systems. Although this concept has been
a goal for some time, it has seldom
been realized. Adding to the difficulty in
addressing this challenge is the fact that
there are few if any templates for how to
achieve this kind of integration, particu-
larly in academic settings where advanced
training has become increasingly compart-
mentalized and narrowly focused [12].
One notable success in this regard is the
Multilateral Initiative on Malaria (MIM),
which was established in 1997 as a com-
ponent of the United Nations Children’s
Fund (UNICEF) - United Nations Devel-
opment Programme (UNDP) - World
Bank - World Health Organization Spe-
cial Programme for Research and Train-
ing in Tropical Diseases (WHO TDR).
The stated mission of MIM is ‘‘to streng-
then and sustain through collaborative
research and training, the capacity of
malaria-endemic countries in Africa to
carry out research that is required to
develop and improve tools for malaria
control and to strengthen the research-
control interface.’’ The MIM has also
embraced bureaucratic and regulatory
challenges, which must be accounted for
in any VBD management plan because
they continue to be significant barriers
that discourage reciprocal exchanges be-
tween laboratory and field [29] (Table S3,
B). MIM has increased the priority of
malaria on political agendas to secure
additional resources for education and
control.
The effectiveness and sustainability of
control interventions will require greater
recognition and incorporation of the
integrated nature of vector physiology into
control programs (Table S4, B). For
example, there is significant metabolic
‘‘cross-talk’’ among mechanisms underly-
ing insecticide resistance, lifespan, repro-
duction, and immunity, and among the
regulatory pathways that mediate these
processes [30–32]. Strategies that target
a single physiology will likely influence
others. Consequently, this interplay among
physiological processes demands attention
in research on the biology and control of
vectors (Table S4, C).
Scientific Meetings and Training
Although vector biologists can choose
from a variety of scientific meetings to
attend, few emphasize higher-level inter-
actions across disciplines. VBD researchers
would benefit from disease-specific scien-
tific meetings that require researchers to
communicate across epidemiology, sys-
tems biology, modeling, vector biology
and control, health system delivery, and
social sciences and to network with
researchers engaged in research on water
management, agriculture, vaccine and
drug development, and diagnostics. The
goal should be to encourage scientists to
step outside of their comfort zones so that
they develop new lines of communication
that are critical for holistic management of
hosts, pathogens, and the environment.
Collaboration across disciplines will sub-
stantially improve the prospects for sus-
tainable VBD control.
Training programs that are focused
exclusively on vectors and their biology
and ecology are few and available to a
relatively small group of students. For 18
years the Biology of Disease Vectors (BDV)
course (http://www.cvmbs.colostate.edu/
mip/bdv/), supported by UNICEF-
UNDP-World Bank-WHO TDR and the
John D. and Catherine T. MacArthur
Foundation, served as an example of the
effectiveness of broad-based vector biology
training [8]. The course provided intensive
training in vector biology/ecology for
young scientists from around the world
that inspired new ideas and collaborations
that lasted long after the course had ended.
The BDV course is an example of the
positive impact that training programs can
have when they are adequately supported,
both financially and intellectually, by the
research community. Because the course is
no longer available in its original form
there is an urgent need for new interna-
tional training programs to stimulate and
engage young vector biologists (Table S3,
A). Such programs should integrate disci-
plines and provide broad training for a
large number of investigators, with the goal
of improving networking and collaboration
among scientists from disease-endemic and
nonendemic countries.
An underutilized and too often over-
looked resource for bridging integration is
the combined strengths of academic and
government/military research units (Table
S3, B). Collaboration across these units can
enhance and extend academic training and
also stabilize and enhance government/
military research and overseas laboratories.
Government and military overseas labora-
tories with traditional strengths in VBD
research have resources and well-estab-
lished field sites that are unique, often in
disease-endemic areas. Recently, some of
these programs have seen significant reduc-
tions in funding and shifts in focus away
from VBDs; they may be in danger of
elimination [12]. Conversely, academic
VBD training has struggled to provide the
invaluable hands-on experience that exists
at government and military overseas labo-
ratories. Harnessing the combined strengths
of academic, government, and military
laboratories will result in an enriched
environment for students and trainees.
Sustainability
Infrastructure, Resources, and
Advocacy
Sustainability of successful VBD inter-
ventions and the research that supports
those efforts will depend on strong intel-
lectual and physical infrastructure, stake-
holder enfranchisement, and political buy-
in. In disease-endemic countries, the
ability to sustain effective VBD prevention
requires local expertise; e.g., continued
training at all levels, development of
professional degree programs (thesis and
nonthesis MSc as well as PhD), and
professionalization of vector control as a
discipline (Table S3, A). Infrastructure and
resources could be leveraged across much
of the VBD-endemic world by developing
and maintaining stock and strain storage
centers for pathogens and vectors, provid-
ing greater access to vector infection assays
and containment facilities, offering on-line
courses and resources, opening access to
well-characterized field sites, and continu-
ing expansion of publicly available tech-
nology and reference reagent centers in
endemic and nonendemic countries (Table
S3, B). The National Institutes of Health
National Center for Research Resources,
which serves many research areas, could
function as a prototype for the develop-
ment of additional VBD-specific research
resources. Success of these kinds of pro-
grams will require scientific and policy
advocacy groups/programs that effectively
promote interventions and required fund-
ing to decision-makers, policy-makers, and
the people who implement those pro-
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viding advocates with data and concepts
that are needed to effectively argue for
enhanced VBD research.
Heterogeneity
Host, Pathogen, and Environment
Heterogeneity is increasingly recog-
nized as having fundamentally power-
ful impacts on infectious disease dynam-
ics [32,33]. Compared to non-vector-
borne pathogens, the insertion of vec-
tor into the transmission cycle exponen-
tially increases the complexity of the
system. Heterogeneities derive from the
natural and social environment (spatial
and temporal), from the organisms in
the VBD cycle, and from coinfecting
pathogens. Rapid expansion of human
populations and anthropogenic change
drive the need for expanded capaci-
ties to monitor, analyze, and model
heterogeneity.
As with most difficult problems, there
is a desire to identify simple solutions.
However, the growing disease burden,
despite decades of effort, is a testament
to pathogen and vector persistence and to
the resilience of VBD cycles. Enhanced
computational power constitutes an op-
portunity for vector biologists to more fully
embrace heterogeneity in the organisms
and systems they study and to more
effectively use that knowledge to improve
VBD surveillance and prevention pro-
grams (Table S1, A/B). Ultimately, these
advances can be implemented as decision
support systems that are sufficiently user
friendly and flexible to be available in real
time and to reflect changing social,
biological, economic, ethical, and medical
needs. For example, natural heterogeneity
in mosquito movement [33], human move-
ment [34], preferred hosts, and the indi-
viduals who contribute most to infection
[35,36] can be used to map spatial and
temporal patterns of mosquito-borne dis-
eases and, hence, to improve the efficacy of
control efforts.
Conclusions
In light of current global changes in
VBD transmission and in technological
and research advancements, a reevalua-
tion of the VBD research agenda is
needed. This must be a community-based
evolution that results in effective and
sustainable disease control, not the pro-
duction of a static document that rapidly
becomes obsolete and irrelevant. The
vision of the future is broader and more
holistic than the past, looking at new,
multiple, and integrated methods for
combating VBDs. Success will require
that vector biologists more effectively
engage with clinicians, epidemiologists,
and other natural and social scientists.
The future requires breaking down silos,
thinking about using combinations of tools
for disease control, and attacking multiple
diseases. Although some portions of this
agenda have been reviewed previously, we
have focused on those issues that remain
relevant, added new ones, and have
attempted to move past those that are
no longer relevant. Indeed, we seek to
stimulate a new discussion and new
actions for the discipline of vector biology.
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